Nephrocare Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve the Audited Standalone ....
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Nephrocare Health Services Ltd has informed exchanges that its Board meeting is scheduled for May 19, 2026 to consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026. The company has also confirmed that the trading window remains closed for all Designated Persons and their immediate relatives from April 01, 2026 till May 21, 2026. This is a standard regulatory intimation under SEBI Listing Regulations. No specific financial figures or auditor opinions are disclosed in this filing as the meeting has not yet taken place.
This is a routine pre-result announcement. The actual financial performance and any material disclosures will be known only after the meeting. Shareholders should await the results announcement post-May 19, 2026 for any investment-relevant information.